CRW Craneware plc
Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. It offers Trisus, a cloud-native healthcare financial intelligence platform that unifies data, revenue and margin insights, and operational analytics; Trisus Pricing Integrity Suite, which includes a portfolio of solutions that ensure the chargemaster is accurate, defensible, and aligned with market realities; Trisus Business of Pharmacy suite, which provides a portfolio of solutions centered on each link in the medication revenue cycle; Healthcare Intelligence Suite, a portfolio of solutions that centralizes key operational data comprising costs, staffing and performance; and Trisus Data Integrity Suite, which creates a workflow that aligns the supply chain and revenue cycle. The company was incorporated in 1999 and is headquartered in Edinburgh, the United Kingdom.…
Industry Peers
Health Information ServicesKey Statistics
About Craneware (LON: CRW)
›
Craneware (LON: CRW) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Health Information Services industry, part of the Healthcare sector, and reports about 808 employees.
The shares were at 1016.00 GBp on 19 November 2026, down 53.0% over 52 weeks.
At a market capitalisation of 349.35M GBP, it trades at 24.2 times trailing earnings and 14.7 times forward earnings. The median trailing P/E of its 14 largest Health Information Services peers is 42.1, a discount of 43% for CRW. It pays a dividend yielding 3.30% (it pays out 80% of its earnings).
Craneware reports return on equity of 6.2%, an operating margin of 12.9% and revenue down 5.1% year over year.
It holds more cash than debt, a net cash position of 8.29M USD. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. 5 analysts cover the stock; their mean price target of 1826.54 GBp is 79.8% above the current price.